SQZ Biotechnologies Total Liabilities

SQZ Biotechnologies (SQZ) currently reports a total liabilities of $28M as of September 2023. That compares with $86M in the prior-year period — down 67.7% year over year. Use the charts on this page to explore SQZ Biotechnologies's total liabilities history and peer comparisons.

SQZ Biotechnologies's total liabilities decreased from $86M to $28M — a 67.7% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SQZ Biotechnologies reported $28M in total liabilities as of September 2023. That compares with $86M in the prior-year period — down 67.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $28M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SQZ Biotechnologies, and consider following SQZ for alerts when major investors trade the stock.

SQZ Biotechnologies is classified in the Healthcare sector. On total liabilities, it currently shows $28M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SQZ with unrelated industries.